Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Pliant Therapeutics Inc

PLRX
11,37
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:49:43
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/1/202500:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/1/202500:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/1/202500:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202523:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202500:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202500:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202523:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202523:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202522:23EDGAR2Form 144 - Report of proposed sale of securities
22/1/202522:00GLOBEPliant Therapeutics Announces Inducement Grant Under Nasdaq..
22/1/202514:00GLOBEPliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief..
02/1/202514:00GLOBEPliant Therapeutics to Participate in the 43rd Annual J.P...
21/11/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
19/11/202400:00GLOBEPliant Therapeutics Presents Data from its Bexotegrast..
14/11/202423:05EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202422:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:14EDGAR2Form 8-K - Current report
07/11/202422:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
06/11/202414:00GLOBEPliant Therapeutics to Participate in the Stifel Healthcare..
17/10/202414:00GLOBEPliant Therapeutics INTEGRIS-PSC Phase 2a Data Evaluating..
04/10/202423:34EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
01/10/202422:35GLOBEPliant Therapeutics Appoints Gary Palmer, M.D. as Senior..
30/9/202422:45GLOBEPliant Therapeutics Announces Inducement Grant Under Nasdaq..
27/9/202422:11EDGAR2Form 8-K - Current report
24/9/202414:00GLOBEAligos Therapeutics Strengthens Senior Leadership Team with..
10/9/202414:00GLOBEPliant Therapeutics Presents Data from its Bexotegrast..
28/8/202414:00GLOBEPliant Therapeutics to Participate in Upcoming Investor..
26/8/202415:10GLOBEPliant Therapeutics Announces Four Upcoming Presentations at..
07/8/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202422:08EDGAR2Form 8-K - Current report
07/8/202422:05GLOBEPliant Therapeutics Provides Corporate Update and Reports..
06/8/202422:03GLOBEPliant Therapeutics to Participate in the Canaccord Genuity..
15/7/202417:54EDGAR2Form 8-K - Current report
15/7/202414:00GLOBEPliant Therapeutics Announces Positive Long-Term Data from..
13/7/202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202400:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:04EDGAR2Form 8-K - Current report
13/6/202422:05GLOBEPliant Therapeutics Announces Appointment of Steve Krognes..
12/6/202422:05GLOBEPliant Therapeutics Announces Inducement Grant Under Nasdaq..
06/6/202414:00GLOBEPliant Therapeutics Presents Data from its Bexotegrast..
22/5/202400:50GLOBEPliant Therapeutics Presents Data from its Bexotegrast..
14/5/202413:43EDGAR2Form 8-K - Current report
14/5/202413:30GLOBEPliant Therapeutics Announces Positive Topline Data from a..
07/5/202414:00GLOBEPliant Therapeutics Announces Upcoming Presentations at the..
Apertura: Min: Max:
Chiusura: 11,37

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network